Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Genome Annotation Services Market Growth Potential: How Will Market Size Shift Through 2030?
The market size for genome annotation services has recently experienced substantial growth. It will grow from $1.44 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. This historical growth is attributable to several factors, including the expansion of genome sequencing projects, the increased availability of NGS data, a rise in academic genomics research, the growing use of bioinformatics in drug discovery, and the development of public genomic databases.
The genome annotation services market is poised for significant expansion in the coming years. This market is projected to reach $2.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.9%. This anticipated growth is driven by several factors, including the escalating demand for personalized medicine research, the increasing adoption of AI-driven bioinformatics platforms, the expansion of genomics in precision agriculture, rising investment in genomics startups, and the greater integration of clinical genomics workflows. Key trends during the forecast period encompass a greater reliance on automated gene annotation pipelines, the growing uptake of AI-based functional annotation, a surging demand for comparative genome analysis, the broadening of multi-omics annotation services, and an intensified focus on high-quality manual curation.
Get A Free Sample Report With In-Depth Market Insights:
Genome Annotation Services Market Development Factors: What’s Supporting Demand?
The expanding need for personalized medicine is anticipated to fuel the future expansion of the genome annotation services market. Personalized medicine is a medical strategy that customizes healthcare choices, therapies, and actions based on each patient’s unique attributes, including their genetic makeup, lifestyle, and surroundings. This growing demand for personalized medicine largely stems from the increasing occurrence of chronic and intricate illnesses, given that customized treatments can more precisely address individual patient requirements and enhance results. Genome annotation services facilitate personalized medicine by converting unprocessed genomic data into clinically relevant information, thereby enabling the exact customization of treatments and therapies according to an individual’s genetic profile, risk of disease, and reaction to drugs. For example, data from the Personalized Medicine Coalition, a US-based non-profit organization, reported in February 2024, that in 2023, the U.S. Food and Drug Administration (FDA) sanctioned 16 new personalized treatments for patients with rare diseases, an increase from six in 2022. The personalized treatments given approval in 2023 also encompassed seven cancer drugs and three for various other conditions and diseases. Consequently, the expanding requirement for personalized medicine is stimulating the growth of the genome annotation services market.
Genome Annotation Services Market Segment Analysis Spotlighting Growth Areas
The genome annotation services market covered in this report is segmented –
1) By Service Type: Structural Annotation; Functional Annotation; Comparative Annotation; Other Service Types
2) By Technology: Next Generation Sequencing; Sanger Sequencing; Other Technologies
3) By Application: Drug Discovery; Personalized Medicine; Agriculture; Biotechnology; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Clinical Laboratories; Other End-Users
Subsegments:
1) By Structural Annotation: Gene Prediction Annotation; Exon Intron Boundary Identification; Regulatory Element Identification; Repeat Sequence Identification; Non Coding Region Annotation
2) By Functional Annotation: Gene Ontology Assignment; Protein Function Characterization; Pathway Mapping Annotation; Protein Domain Identification; Enzyme Activity Annotation
3) By Comparative Annotation: Cross Species Genome Comparison; Ortholog Identification; Paralog Identification; Evolutionary Conservation Analysis; Synteny Mapping Annotation
4) By Other Service Types: Customized Genome Annotation Services; Integrated Multi Omics Annotation; Manual Curation Services; Annotation Quality Validation Services; Database Integration Services
Genome Annotation Services Market Transformation Trends: What Innovations Are Driving Change?
Major companies operating in the genome annotation services market are emphasizing the development of new in-house prokaryotic genome annotation pipelines to deliver more consistent, accurate, and scalable annotations across extensive genome datasets. These novel in-house prokaryotic genome annotation pipelines employ standardized, automated workflows that combine advanced gene prediction and functional annotation tools to produce consistent, high-quality annotations for large quantities of microbial genomes. For instance, in July 2023, the European Molecular Biology Laboratory’s European Bioinformatics Institute, a UK-based molecular biology laboratory, launched a comprehensive new annotation for all genomes hosted in Ensembl Bacteria. This update introduced a standardized, in-house prokaryotic annotation pipeline, replacing the earlier reliance on heterogeneous submitter-provided annotations. The initiative successfully delivered consistent gene prediction, functional annotation, and systematic gene identifiers across tens of thousands of bacterial and archaeal genomes. Overall, the release significantly improved data comparability, annotation quality, and usability for large-scale comparative genomics and microbiome research.
Genome Annotation Services Market Leading Companies And Competitive Benchmarking
Major companies operating in the genome annotation services market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Charles River Laboratories International Inc., QIAGEN N.V., Macrogen Inc., Novogene Co. Ltd., Pacific Biosciences of California Inc., SOPHiA GENETICS, DNAnexus Inc., Zymo Research Corporation, GOENOMICS GmbH, CD Genomics, Eagle Genomics Ltd., DNASTAR Inc., Lexogen GmbH, Beijing Genomics Institute Group, and BioBam Bioinformatics S.L.
View The Full Genome Annotation Services Market Report:
Genome Annotation Services Market Top Region By Revenue And Market Share
North America was the largest region in the genome annotation services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period The regions covered in the genome annotation services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
